Eli Lilly reports 15% rise in quarterly sales

This post was originally published on this site

https://i-invdn-com.akamaized.net/news/LYNXMPED3O0LI_M.jpg

Its quarterly revenue rose to $5.86 billion from $5.09 billion a year earlier.

However, net income fell to $1.46 billion, or $1.60 per share, in the quarter ended March 31, from $4.24 billion, or $4.31 per share, a year earlier when it recorded a gain of $3.68 billion from the sale of Elanco Animal Health . (N:ELAN).